Reports Stack News and Updates
World – Efforts are on to find a cure for incurable diseases like HIV AIDS. The scientists of Tel Aviv University have achieved important success. Scientists made some changes in the genes of type-B white blood cells present in the body, due to which the HIV virus died. A few days ago, there was a success in curing rectal cancer patients.
After cancer, scientists have probably achieved great success in getting rid of an incurable diseases like HIV-AIDS. Scientists have succeeded in making such a vaccine, whose single dose can kill the HIV virus. The lab results of this vaccine, prepared by researchers from Tel Aviv University in Israel, have been very positive. Scientists made some changes in the genes of type-B white blood cells present in the body, which broke down the HIV virus. This breakthrough has raised hope that even a cure for a disease like HIV-AIDS is not far off.
There is no cure for HIV-AIDS yet. However, with medicines, the disease can be stopped from spreading and a person infected with HIV can live for a long time. This disease is spread by HIV ie Human Immunodeficiency Virus. This virus attacks the body’s immune system. If it is not treated, it can lead to AIDS.
To break this incurable disease, a team of scientists led by Dr. Adi Bargel used type-B white blood cells. These cells produce antibodies to fight viruses and dangerous bacteria in our bodies. These white blood cells are made in the bone marrow. When mature, they reach the body parts through the blood. The scientists interacted with parts of the HIV virus by modifying the genes of these B cells. This brought some change to them. After that these prepared B cells competed with the HIV virus, then the virus appeared to break down.
Dr. Barzel said that the models on which the treatment was tested in the lab showed very good results. The number of antibodies in his body also increased significantly and were successful in eliminating the HIV virus. This research has been published in Nature magazine. In its conclusion, the medical journal has described these antibodies as safe, potent, and workable.
